Bioinformatics Solutions Inc. (BSI) releases PEAKS AB 2.0. The comprehensive software is used by leading biopharma companies and research facilities for characterizing monoclonal antibodies (mAbs) directly from mass spectrometry data.
The latest features added to the software include:
- Upgraded de novo sequencing and assembly algorithm
- Capability of analyzing EThcD data
- Enhanced 3-tier Ile/Leu discrimination
- Greater customization capabilities
- Intact mass deconvolution analysis
The software provides antibody researchers with an automated data analysis solution, saving time and enhancing accuracy. Visit PEAKS AB Software to learn more about this tool and PEAKS AB 2.0 to learn more about its newest features.
Users are welcome to schedule a free consultation with BSI experts in order to learn more about both the antibody sequencing software and service.